Peter D. Suzdak
2015
In 2015, Peter D. Suzdak earned a total compensation of $1.1M as Chief Executive Officer at Rexahn Pharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Option Awards | $629,484 |
|---|---|
| Salary | $430,000 |
| Other | $12,947 |
| Total | $1,072,431 |
Suzdak received $629.5K in option awards, accounting for 59% of the total pay in 2015.
Suzdak also received $430K in salary and $12.9K in other compensation.
Rankings
In 2015, Peter D. Suzdak's compensation ranked 7,607th out of 13,638 executives tracked by ExecPay. In other words, Suzdak earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,607 out of 13,638 | 44th |
Division Manufacturing | 2,885 out of 5,190 | 44th |
Major group Chemicals And Allied Products | 1,042 out of 1,854 | 44th |
Industry group Drugs | 839 out of 1,528 | 45th |
Industry Pharmaceutical Preparations | 660 out of 1,182 | 44th |
Source: SEC filing on February 24, 2017.
Suzdak's colleagues
We found three more compensation records of executives who worked with Peter D. Suzdak at Rexahn Pharmaceuticals in 2015.